Quint Hasenbein

Quint Hasenbein is a seasoned professional in market access and corporate account management with extensive experience in the biopharmaceutical industry. Currently serving as National Corporate Account Director at Sumitomo Pharma America, Inc., Quint is responsible for strategic initiatives, alliances, and contracting within various specialty pharmacy and distribution networks. Prior roles include Director of GPO and Trade at Clovis Oncology and a cross-functional market access position at Spectrum/Acrotech Bio-Pharmaceuticals, where Quint demonstrated expertise in payer strategies and reimbursement. Quint's career began in education, transitioning to sales roles at the pharmaceutical companies Johnson & Johnson and inVentiv Health, among others. Quint holds a Master’s degree in Leadership and Administration and a Bachelor’s degree in Education from the University of South Alabama.